The European Patent Office published patent application EP3642337A1 titled 'Therapy and Diagnosis of Disease Characterised by Alterations in the DNA Damage Response'. The applicants are IFOM – Fondazione Istituto FIRC di Oncologia Molecolare and Istituto Europeo di Oncologia S.r.l., both Italian cancer research institutions. The application is classified under C12N 9/16, A61K 31/155, and A61K 8/68, with designated states covering all European Patent Convention member states and extension states.
RoutineNoticeIntellectual Property
Get alerts for "IFOM - Fondazione Istituto FIRC di Oncologia Molecolare"
